![ESMO Breast 2022_venue](/var/esmo/storage/images/media/esmo-daily-reporter/images/esmo-breast-2022/esmo-breast-2022_venue/11076668-1-eng-GB/esmo-breast-2022_venue_i770.jpg)
Results suggest the efficacy of trastuzumab deruxtecan is influenced by the spatial distribution of HER2 in breast tumour cells
A translational analysis of the DAISY trial improves knowledge on the mechanisms of action of the antibody–drug conjugate